Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge (opens in new tab)
W Bulten, K Kartasalo, PHC Chen, P Ström, H Pinckaers, K Nagpal, Y Cai, ...
28 (1), 154-163 2022
About me
Wouter Bulten
Chief Operating & Product Officer of Aiosyn, an AI startup focused on computational pathology. I hold a PhD in AI for clinical diagnostics. This website is a portfolio of things I work on, both professionally and as a hobby, from home automation to cooking.
Career
Aiosyn · AI-powered diagnostics
2021 – present Feb 2024 – Present Chief Operating & Product Officer
Leading operations and product strategy at Aiosyn, an AI startup in computational pathology.
- Brought AI-based pathology software through CE-IVDR certification.
- Responsible for product, quality management, and day-to-day operations.
Aug 2021 – Jan 2024 Chief Innovation Officer
Translational research and early product development in AI-assisted digital pathology.
Radboud University Medical Center · Computational Pathology Group
2017 – 2021 May 2021 – Aug 2021 Postdoctoral Researcher
Post-doctoral research in computational pathology and AI-based tissue analysis.
Apr 2017 – Apr 2021 PhD Candidate
Doctoral research on deep learning for prostate cancer diagnosis.
- First-author publications in The Lancet Oncology and Nature Medicine.
- Contributed to the PANDA challenge, a global AI competition on prostate cancer grading.
123test / TestingTalents · Online psychological testing
2011 – 2017 Apr 2016 – Mar 2017 Data Scientist
Machine learning and data-driven features for psychometric assessments.
Feb 2011 – Mar 2016 Software Developer
Web applications and tooling for online psychological testing.
DoBots / Almende · Robotics & wireless sensor networks
2014 – 2015 Oct 2014 – Aug 2015 Research Intern
Indoor localisation and IoT research using wireless sensor networks.
OuterHills · Freelance web & software development
2009 – 2021 Sept 2009 – Aug 2021 Freelance Developer
Freelance web and software development for a range of clients.
Publications & Media
Key Publications
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists (opens in new tab)
W Bulten, M Balkenhol, JJA Belinga, A Brilhante, A Çakır, L Egevad, ...
34 (3), 660-671 2021
Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study (opens in new tab)
W Bulten, H Pinckaers, H van Boven, R Vink, T de Bel, B van Ginneken, ...
21 (2), 233-241 2020
In the Media
DataNews · 2023
Vijf manieren waarop AI ziekte opspoortComputable · 2022
Radboudumc scoort met ai-analyse prostaatweefselMedische Oncologie · 2022
Kunstmatige intelligentie als digitale collega voor de patholoogRTL Nieuws Opinie · 2022
Artificial intelligence kan onze zorg reddenICT&Health · 2022
Combinatie AI en patholoog kan diagnostiek sterk verbeterenNTvG · 2020
Beste oordeel komt van mens en machine samenKIJK Magazine · 2020
Digitale Dokters - Wat AI voor de medische wereld kan betekenenCosmos · 2020
Prostate diagnosis may benefit from some deep learningBNR Wetenschap Vandaag · 2020
De computer is slimmer dan de patholoogEducation
PhD
Mar 2017 – Jan 2022
Computational Pathology & Artificial Intelligence
Radboud University, Nijmegen
Deep learning for automated Gleason grading of prostate cancer biopsies.
MSc
Sept 2012 – Aug 2015
Artificial Intelligence (cum laude)
Radboud University, Nijmegen
Thesis: Human SLAM – Indoor Localisation of Devices and Users.
BSc
Sept 2009 – Aug 2012
Artificial Intelligence (cum laude)
Radboud University, Nijmegen
Thesis: Decentralized trust ecosystems.
Medical Device Training
Ongoing
ISO 13485, CE-IVDR, ISO 27001, ISO 14971
Regulatory training for medical device development and quality management.
Let's talk
I'm always happy to discuss AI in healthcare, building regulated products, or anything at the intersection of fields.